Previous 10 | Next 10 |
Privately held Proteona announces that Twist Bioscience ( TWST +0.4% ) has joined an international alliance led by Proteona aimed at developing neutralizing antibody therapies against COVID-19 for vulnerable immunocompromised patients. More news on: Twist Bioscience Corporation, Heal...
Proteona today announced that Twist Bioscience Corporation (Nasdaq: TWST) will join the international alliance led by Proteona to develop neutralizing antibody therapy against COVID-19 for vulnerable immunocompromised patients. Utilizing the highly parallel silicon-based DNA synthesis platf...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the Jefferies Virtual Healthc...
Gainers: RVLV +11.3% . VERI +9.1% . FRAN +5.8% . TWST +4.9% . UPWK +4.6% . More news on: Revolve Group, Inc., Veritone, Inc., Francesca's Holdings Corporation, Stocks on the move, , Read more ...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO, will participate in th...
Twist Bioscience Corporation (TWST) Q2 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Emily Leproust - Chief Executive Officer and Co-Founder Jim Thorburn - Chief Financial Officer Conference Call Participants Subbu Nambi - Cowen Luke Sergott - Ev...
Image source: The Motley Fool. Twist Bioscience Corp (NASDAQ: TWST) Q2 2020 Earnings Call May 8, 2020 , 8:30 p.m. ET Operator Continue reading
The following slide deck was published by Twist Bioscience Corporation in conjunction with their 2020 Q2 earnings Read more ...
Twist Bioscience (NASDAQ: TWST ): Q2 GAAP EPS of -$0.85 misses by $0.09 . More news on: Twist Bioscience Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
-- Strong Second Quarter Fiscal 2020 Revenues of $19.3M; Increase of 42% over Second Quarter Fiscal 2019 -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported f...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...